{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-064879","form_type":"8-K","ticker":"EYPT","cik":"0001314102","company_name":"EyePoint, Inc.","filed_at":"2024-05-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.796998+00:00","generated_at":"2026-06-01T07:55:06.579451+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"EyePoint posts updated investor presentation; no specific financial updates in excerpt","bullets":["Filed investor presentation dated May 2024 as Exhibit 99.1 on May 28, 2024.","Presentation posted on company website at www.eyepointpharma.com.","No new financial guidance, clinical data, or material events disclosed in filing summary.","Ticker EYPT; common stock listed on Nasdaq.","No changes to previously disclosed business outlook or pipeline."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-064879","json":"https://secwatch.observer/filing/0000950170-24-064879.json","markdown":"https://secwatch.observer/filing/0000950170-24-064879.md","text":"https://secwatch.observer/filing/0000950170-24-064879.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314102/000095017024064879/0000950170-24-064879-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314102/000095017024064879/eypt-20240528.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:55:06.579451+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}